455 related articles for article (PubMed ID: 18073374)
21. The NBN founder mutation-Evidence for a country specific difference in age at cancer manifestation.
Chrzanowska KH; Seemanova E; Varon R; Digweed M; Piekutowska-Abramczuk D; Sperling K; Seeman P
Cancer Rep (Hoboken); 2023 Feb; 6(2):e1700. PubMed ID: 36806726
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer incidence and the effect of cigarette smoking in heterozygous carriers of mutations in the ataxia-telangiectasia gene.
Swift M; Lukin JL
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3188-92. PubMed ID: 18990761
[TBL] [Abstract][Full Text] [Related]
23. Screening of Nijmegen breakage syndrome 1 mutations in four unrelated families by polymerase chain reaction using sequence-specific primers.
Di Masi A; Antoccia A; Spadoni E; Varon-Mateeva R; Maraschio P; Tanzarella C
Genet Test; 2006; 10(1):24-30. PubMed ID: 16544999
[TBL] [Abstract][Full Text] [Related]
24. Cleavage of the BRCT tandem domains of nibrin by the 657del5 mutation affects the DNA damage response less than the Arg215Trp mutation.
Mendez G; Cilli D; Berardinelli F; Viganotti M; Ascenzi P; Tanzarella C; Antoccia A; di Masi A
IUBMB Life; 2012 Oct; 64(10):853-61. PubMed ID: 22941933
[TBL] [Abstract][Full Text] [Related]
25. Nijmegen breakage syndrome in 13% of age-matched Czech children with primary microcephaly.
Seeman P; Gebertová K; Paderová K; Sperling K; Seemanová E
Pediatr Neurol; 2004 Mar; 30(3):195-200. PubMed ID: 15033202
[TBL] [Abstract][Full Text] [Related]
26. An inducible null mutant murine model of Nijmegen breakage syndrome proves the essential function of NBS1 in chromosomal stability and cell viability.
Demuth I; Frappart PO; Hildebrand G; Melchers A; Lobitz S; Stöckl L; Varon R; Herceg Z; Sperling K; Wang ZQ; Digweed M
Hum Mol Genet; 2004 Oct; 13(20):2385-97. PubMed ID: 15333589
[TBL] [Abstract][Full Text] [Related]
27. [Clinical and genealogical characteristics in families with Nijmegen breakage syndrome].
Kitsera NI; Polishchuk RS; Akopian HR; Markevych NV; Kostiuchenko LV; Troianovs'ka OO; Skoropad LL
Tsitol Genet; 2005; 39(2):72-8. PubMed ID: 16161417
[TBL] [Abstract][Full Text] [Related]
28. Cancer incidence in Nijmegen breakage syndrome is modulated by the amount of a variant NBS protein.
Krüger L; Demuth I; Neitzel H; Varon R; Sperling K; Chrzanowska KH; Seemanova E; Digweed M
Carcinogenesis; 2007 Jan; 28(1):107-11. PubMed ID: 16840438
[TBL] [Abstract][Full Text] [Related]
29. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study.
Balaguer F; Castellví-Bel S; Castells A; Andreu M; Muñoz J; Gisbert JP; Llor X; Jover R; de Cid R; Gonzalo V; Bessa X; Xicola RM; Pons E; Alenda C; Payá A; Piqué JM;
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):379-87. PubMed ID: 17368238
[TBL] [Abstract][Full Text] [Related]
30. Radiation-induced DNA damage and repair in peripheral blood mononuclear cells from Nijmegen breakage syndrome patients and carriers assessed by the Comet assay.
Bürger S; Schindler D; Fehn M; Mühl B; Mahrhofer H; Flentje M; Hoehn H; Seemanová E; Djuzenova CS
Environ Mol Mutagen; 2006 May; 47(4):260-70. PubMed ID: 16470524
[TBL] [Abstract][Full Text] [Related]
31. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
32. Nijmegen breakage syndrome: clinical characteristics and mutation analysis in eight unrelated Russian families.
Resnick IB; Kondratenko I; Togoev O; Vasserman N; Shagina I; Evgrafov O; Tverskaya S; Cerosaletti KM; Gatti RA; Concannon P
J Pediatr; 2002 Mar; 140(3):355-61. PubMed ID: 11953735
[TBL] [Abstract][Full Text] [Related]
33. Retrospective diagnosis and subsequent prenatal diagnosis of Nijmegen breakage syndrome.
Muschke P; Gola H; Varon R; Röpke A; Zumkeller W; Wieacker P; Stumm M
Prenat Diagn; 2004 Feb; 24(2):111-3. PubMed ID: 14974117
[TBL] [Abstract][Full Text] [Related]
34. NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia.
Buslov KG; Iyevleva AG; Chekmariova EV; Suspitsin EN; Togo AV; Kuligina ESh; Sokolenko AP; Matsko DE; Turkevich EA; Lazareva YR; Chagunava OL; Bit-Sava EM; Semiglazov VF; Devilee P; Cornelisse C; Hanson KP; Imyanitov EN
Int J Cancer; 2005 Apr; 114(4):585-9. PubMed ID: 15578693
[TBL] [Abstract][Full Text] [Related]
35. The clinical manifestation of a defective response to DNA double-strand breaks as exemplified by Nijmegen breakage syndrome.
Demuth I; Digweed M
Oncogene; 2007 Dec; 26(56):7792-8. PubMed ID: 18066092
[TBL] [Abstract][Full Text] [Related]
36. Identification of the interactors of human nibrin (NBN) and of its 26 kDa and 70 kDa fragments arising from the NBN 657del5 founder mutation.
Cilli D; Mirasole C; Pennisi R; Pallotta V; D'Alessandro A; Antoccia A; Zolla L; Ascenzi P; di Masi A
PLoS One; 2014; 9(12):e114651. PubMed ID: 25485873
[TBL] [Abstract][Full Text] [Related]
37. Mutations in the Nijmegen breakage syndrome gene in medulloblastomas.
Huang J; Grotzer MA; Watanabe T; Hewer E; Pietsch T; Rutkowski S; Ohgaki H
Clin Cancer Res; 2008 Jul; 14(13):4053-8. PubMed ID: 18593981
[TBL] [Abstract][Full Text] [Related]
38. Incidence of cancer in 161 families affected by ataxia-telangiectasia.
Swift M; Morrell D; Massey RB; Chase CL
N Engl J Med; 1991 Dec; 325(26):1831-6. PubMed ID: 1961222
[TBL] [Abstract][Full Text] [Related]
39. Germline NBS1 mutations in families with aggregation of Breast and/or ovarian cancer from north-east Poland.
Kanka C; Brozek I; Skalska B; Siemiatkowska A; Limon J
Anticancer Res; 2007; 27(4C):3015-8. PubMed ID: 17695489
[TBL] [Abstract][Full Text] [Related]
40. Cancer risks in LKB1 germline mutation carriers.
Mehenni H; Resta N; Park JG; Miyaki M; Guanti G; Costanza MC
Gut; 2006 Jul; 55(7):984-90. PubMed ID: 16407375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
